Pradeep R., Nemichandra S. C., Harsha S., Radhika K. 2020. Migraine disability, quality of life, and its predictors. Ann. Neurosci. 27 (1), 18. https://doi.org/10.1177/0972753120929563
Xu H., Han W., Wang J., Li M. 2016. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. J. Head. Pain. 17, 1–18. https://doi.org/10.1186/s10194-016-0703-0
Deen M., Correnti E., Kamm K., Kelderman T., Papetti L., Rubio-Beltrán E., et al. 2017. Blocking CGRP in migraine patients–a review of pros and cons. J. Head. Pain. 18, 1–9. https://doi.org/10.1186/s10194-017-0807-1
Olesen J., Burstein R., Ashina M., Tfelt-Hansen P. 2009. Origin of pain in migraine: Evidence for peripheral sensitisation, Lancet. Neur. 8 (7), 679–690. https://doi.org/10.1016/S1474-4422(09)70090-0
Goadsby P.J., Holland P.R., Martins-Oliveira M., Hoffmann J., Schankin C., Akerman S. 2017. Physiol. Rev. 97 (2), 553–622. https://doi.org/10.1152/physrev.00034.2015
Article PubMed PubMed Central Google Scholar
Edvinsson J.C.A., Viganò A., Alekseeva A., Alieva E., Arruda R., De Luca C., et al. The fifth cranial nerve in headaches. 2020. J. Head. Pain. 21, 1–17. https://doi.org/10.1186/s10194-020-01134-1
Terrier L. M., Hadjikhani N., Velut S., Magnain C., Amelot A., Bernard F., et al. 2021. The trigeminal system: The meningovascular complex—a review. J. Anat. 239 (1), 1–11. https://doi.org/10.1111/joa.13413
Article PubMed PubMed Central Google Scholar
Nurkhametova D.F., Koroleva K.S., Gafurov O.S., Giniatullina R.R., Sitdikova G.F., Giniatullin R.A. 2020. Mast cell mediators as pain triggers in migraine: Comparison of histamine and serotonin in the activation of primary afferents in the meninges in rats. Neurosci. Behav. Physiol. 50, 900–906. https://doi.org/10.1007/s11055-020-00983-2
Spekker E., Tanaka M., Szabó Á., Vécsei L. 2021. Neurogenic inflammation: The participant in migraine and recent advancements in translational research. Biomedicines. 10 (1), 76. https://doi.org/10.3390/biomedicines10010076
Article CAS PubMed PubMed Central Google Scholar
Marmura M.J. 2012. Use of dopamine antagonists in treatment of migraine. Curr. Treat. Options Neurol. 14, 27–35. https://doi.org/10.1007/s11940-011-0150-9
Aydin H.D., Vuralli D., Akcali D.T., Belen H.B. 2017. Metoclopramide inhibits trigeminovascular activation: Evidence for effective acute attack treatment in migraine. Turk. J. Med. Sci. 47 (1), 343–347. https://doi.org/10.3906/sag-1601-195
Charbit A.R., Akerman S., Goadsby P.J. 2009. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. J. Pharm. Experim. Therap. 331 (2), 752–763. https://doi.org/10.1124/jpet.109.151951
Barbanti P., Fofi L., Aurilia C., Egeo G. 2013. Dopaminergic symptoms in migraine. Neurol. Sci. 34, 67–70. https://doi.org/10.1007/s10072-013-1415-8
Barbanti P., Aurilia C., Egeo G., Fofi L., Guadagni F., Ferroni P. 2020. Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients. Cephalalgia. 40 (11), 1168–1176. https://doi.org/10.1177/0333102420929023
D’Andrea G., D’Amico D., Bussone G., Bolne, A., Aguggia M., Saracco M.G., et al. 2013. The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia. 33 (11), 932–937. https://doi.org/10.1177/0333102413480755
Martins-Oliveira M., Akerman S., Holland P.R., Tavares I., Goadsby P.J. 2022. Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine. Cephalalgia. 42 (13), 1359–1374. https://doi.org/10.1177/03331024221110111
Article PubMed PubMed Central Google Scholar
Li C., Li Y., Choi W., Ma Z., Xiao S., Xie W., et al. 2023. Dopaminergic projections from the hypothalamic A11 nucleus to the spinal trigeminal nucleus are involved in bidirectional migraine modulation. Int. J. Mol. Sci. 24 (23), 168. https://doi.org/10.3390/ijms242316876
Kurzina N.P., Volnova A.B., Aristova I.Y., Gainetdinov R.R. 2021. A new paradigm for training hyperactive dopamine transporter knockout rats: Influence of novel stimuli on object recognition. Front. Behav. Neurosci. 15, 654469. https://doi.org/10.3389/fnbeh.2021.654469
Article CAS PubMed PubMed Central Google Scholar
Kurzina N., Belskaya A., Gromova A., Ignashchenkova A., Gainetdinov R.R., Volnova A. 2022. Modulation of spatial memory deficit and hyperactivity in dopamine transporter knockout rats via α2A-adrenoceptors. Front. Psychiatry. 13, 851296. https://doi.org/10.3389/fpsyt.2022.851296
Article PubMed PubMed Central Google Scholar
Fesenko Z., Ptukha M., Silva M.M., Carvalho R.S.M., Tsytsarev V., Gainetdinov R.R., et al. 2024. Electrophysiological and behavioral markers of hyperdopaminergia in DAT-KO rats. Biomedicines. 12 (9), 2114. https://doi.org/10.3390/biomedicines12092114
Article CAS PubMed PubMed Central Google Scholar
Leo D., Sukhanov I., Zoratto F., Illiano P., Caffino L., Sanna F., et al. 2018. Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J. Neurosci. 38 (8), 1959–1972. https://doi.org/10.1523/JNEUROSCI.1931-17.2018
Article CAS PubMed PubMed Central Google Scholar
Cinque S., Zoratto F., Poleggi A., Leo D., Cerniglia L., Cimino S., et al. 2018. Behavioral phenotyping of dopamine transporter knockout rats: Compulsive traits, motor stereotypies, and anhedonia. Front. Psychiatry. 9, 43. https://doi.org/10.3389/fpsyt.2018.00043
Article PubMed PubMed Central Google Scholar
Antonova I.V., Kutcher E.O., Filatova E.V., Veraksa A.E., Morina I.Y., Zavialov V.A., et al. 2023. Changes in behavioral characteristics and tyrosine hydroxylase levels in the nucleus accumbens of the brain of DAT-HET rats during free alcoholization. J. Evol. Biochem. Physiol. 59 (2), 586–595. https://doi.org/10.1134/S0022093023020242
Gainetdinov A.R., Fesenko Z.S., Khismatullina Z.R. 2020. Behavioural changes in heterozygous rats by gene knockout of the dopamine transporter (DAT). J. Biomed. (Rus.). 16 (1), 82–88. https://doi.org/10.33647/2074-5982-16-1-82-88
Zhang Y., Wang H., Sun Y., Huang Z., Tao Y., Wang Y., et al. 2023. Trace amine-associated receptor 1 regulation of Kv1. 4 channels in trigeminal ganglion neurons contributes to nociceptive behaviors. J. Head. Pain. 24 (1), 49. https://doi.org/10.1186/s10194-023-01582-5
Harmeier A., Obermuelle, S., Meyer C.A., Revel F.G., Buchy D., Chaboz S., et al. 2015. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers. Eur. Neuropsychopharmacol. 25 (11), 2049–2061. https://doi.org/10.1016/j.euroneuro.2015.08.011
Article CAS PubMed Google Scholar
Espinoza S., Salahpour A., Masri B., Sotnikova T.D., Messa M., Barak L.S., et al. 2011. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol. Pharm. 80 (3), 416–425. https://doi.org/10.1124/mol.111.073304
Koroleva K., Ermakova E., Mustafina A., Giniatullina R., Giniatullin R., et al. 2020. Protective effects of hydrogen sulfide against the atp-induced meningeal nociception. Front. Cell. Neurosci. 14, 266. https://doi.org/10.3389/fncel.2020.00266
Article CAS PubMed PubMed Central Google Scholar
Gafurov O., Koroleva K., Giniatullin R. 2021. Antidromic spike propagation and dissimilar expression of P2X, 5-HT, and TRPV1 channels in peripheral vs. central sensory axons in meninges. Front. Cell. Neurosci. 14, 623134. https://doi.org/10.3389/fncel.2020.623134
Article CAS PubMed PubMed Central Google Scholar
Zakharov A., Vitale C., Kilinc E., Koroleva K., Fayuk D., Shelukhina, I., et al. 2015. Hunting for origins of migraine pain: Cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers. Front. Cell. Neurosci. 9, 287. https://doi.org/10.3389/fncel.2015.00287
Comments (0)